back to
back to

Program: Monday (29.10.2018)

07:30 – 09:00

Scientific Session Advanced Stages

  • Peter Johnson
  • Volker Diehl
  • 07:30–07:50

    ECHELON1 Update

    • John Radford
  • 07:50–08:10

    HD18 Update

    • Peter Borchmann
  • 08:10–08:30

    LYSA AHL2011 Phase III Study

    • Olivier Casasnovas

09:15 – 10:15

Scientific Symposium (by Celgene GmbH) CAR T Cell Therapies: Hype Or Hope?

  • Hermann Einsele
  • 09:15–09:35

    Preclinical Rationale for CAR T Cell Therapy

    • Simone Thomas
  • 09:35–09:55

    CD19 directed CAR T Cell Therapy in B-NHL

    • Peter Borchmann
  • 09:55–10:15

    BCMA directed CAR T Cell Therapy in MM

    • Hermann Einsele

10:30 – 12:00

Scientific Session Pediatric HL

  • Kara Kelly
  • Christine Mauz-Körholz
  • 10:30–10:50

    PD1/-L1 Expression in Pediatric HL

    • Stefan Gattenlöhner
  • 10:50–11:10

    Genotyping in Familial HL

    • Jun Yang
  • 11:10–11:30

    Functional and Financial outcomes after Treatment for Pediatric Hodgkin Lymphoma

    • Susan Parsons

12:15 – 13:45

Scientific Symposium (by MSD) Checkpointblockade in Lymphomas

  • Andreas Engert
  • 12:15–12:35

    Basics in immunotherapy for lymphomas

    • Dominik Wolf
  • 12:35–12:55

    PD-1 blockade current and future aspects of cHL therapy

    • Peter Borchmann
  • 12:55–13:15

    PD-1 blockade in NHLs

    • Pier Luigi Zinzani

14:00 – 15:30

Scientific Session Immunotherapy – Clinical

  • Martin Hutchings
  • Philippe Armand
  • 14:00–14:20

    Checkmate 205: Cohort D

    • Stephen Ansell
  • 14:20–14:40

    Toxicities from Checkpoint Inhibitor Therapy: Diagnosis, Management and Follow-up

    • Paul J. Bröckelmann

15:30 – 16:00

Main Program Poster Session

16:00 – 17:30

Scientific Session Relapsed/Refractory HL

  • Anna Sureda
  • Craig H. Moskowitz
  • 16:00–16:20

    Transplant BRaVE : Phase II trial

    • Anton Hagenbeek
  • 16:20–16:40

    Novel Agents in First Line Salvage

    • Ranjana Advani

17:30 – 18:15

Main Program Closing Remarks

  • Andreas Engert

  • Closing Remarks

    • Andreas Engert

Archive

You a viewing the program of a past symposium. Click here to get back to the current conference.